April 2, 2015

Diplomat Pharmacy on Wednesday completed its acquisition of BioRx. 

April 1, 2015

Diplomat Pharmacy raised almost $200 million in follow-on public offering that closed Tuesday. 

April 1, 2015

The cost of treating rheumatoid arthritis will reach $9.3 billion by 2020, according to a GBI Research report released Wednesday. 

March 30, 2015

Teva Pharmaceutical Industries and Auspex Pharmaceuticals announced an agreement under which Teva will acquire Auspex in a deal valued at $3.2 billion.

March 27, 2015

More than 350 pharmacy advocates headed to Capitol Hill for the seventh annual NACDS RxIMPACT Day to further reinforce the recognition by lawmakers of the evolving role of pharmacy in patient care and educate members of Congress about pro-patient, pro-pharmacy policy.

March 25, 2015

Fred's acquired a specialty pharmacy operation for $66 million.

March 24, 2015

Diplomat Pharmacy commences follow-on public offering of 7.4 million shares of its common stock.

March 18, 2015

Diplomat Pharmacy to offer PARI’s cystic fibrosis treatment Kitabis Pak together with a PARI LC Plus nebulizer handset.

March 16, 2015

Diplomat Pharmacy is looking to raise $200 million with a proposed follow-on public offering of its common stock.

March 12, 2015

Drug Channels Institute on Thursday listed the leading specialty pharmacy players. 

March 12, 2015

CVS Health’s chief medical officer Troyen Brennan said in an interview with Reuters that the entry of copycat biotech drugs could cut prices of expensive medications by 40% to 50%.

March 10, 2015

Impax Labs completed its acquisition of Tower Holdings (which includes operating subsidiaries CorePharma and Amedra Pharmaceuticals), and Lineage Therapeutics. Impax also announced that it would reshape both the operating and reporting structure of its two divisions.

March 10, 2015

The National Association of Specialty Pharmacy on Tuesday announced a headquarter move closer to Capitol Hill. 

February 27, 2015

Remedies for conditions like hepatitis C, NASH (nonalcoholic steatohepatitis) and oncology will all help contribute to growth within the biotech sector, according to an analysis from Bloomberg Intelligence. 

February 27, 2015

GlaxoSmithKline expects to complete its Novartis transaction in the week commencing March 2.

February 26, 2015

Diplomat Pharmacy on Thursday acquired the specialty pharmacy BioRx.

 

February 26, 2015

A team of researchers at Columbia Engineering has developed a low-cost smartphone accessory that can perform a point-of-care test for HIV or syphilis in just 15 minutes.

 

February 25, 2015

Diplomat Pharmacy to dispense new multiple myeloma treatment from Novartis. 

February 23, 2015

Diplomat Pharmacy's Phil and Jocelyn Hagerman gift $5 million to the Ferris State University’s College of Pharmacy. 

February 19, 2015

Walgreens on Thursday announced that Ibrance (palbociclib) is immediately available through Walgreens Specialty Pharmacy.

February 17, 2015

CVS Health weighs in on the next chapter in the debate about the impact of expensive drugs on the healthcare system in a commentary that appears today on the Health Affairs blog.

February 17, 2015

The Food and Drug Administration has approved Lenvima (lenvatinib) for the treatment of differentiated thyroid cancer. 

February 17, 2015

The Food and Drug Administration last week issued five draft documents related to drug compounding and repackaging that will help entities comply with important public health provisions.

February 9, 2015

Onco360 on Monday announced that it has been selected by Pfizer as a limited-distribution pharmacy network participant for Ibrance (palbociclib), Pfizer’s recently approved product for certain breast cancers.